or Try an Advanced Search...

    Technical Analysis for CABA - Cabaletta Bio, Inc.

    Grade Last Price % Change Price Change
    F 7.81 4.41% 0.33
    CABA closed up 4.41 percent on Monday, July 1, 2024, on 65 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CABA trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish 4.41%
    Wide Bands Range Expansion 4.41%
    Up 3 Days in a Row Strength 4.41%
    Oversold Stochastic Weakness 4.41%
    NR7 Range Contraction 6.40%
    NR7-2 Range Contraction 6.40%
    Older End-of-Day Signals for CABA ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 7 hours ago
    60 Minute Opening Range Breakout about 8 hours ago
    Up 3% about 9 hours ago
    Rose Above Previous Day's High about 10 hours ago
    Down 2 % about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CABA Chart by TradingView
    Basic chart:

    Profile

    Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Immunology Autoimmune Disease Antibodies Autoimmunity T Cell Sjögren Syndrome

    Is CABA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Cabaletta Bio: Next Data Readout Needs To Be Mic Drop Moment
    Jun 14 Cabaletta Bio slips after early data for lead asset
    Jun 14 Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
    May 29 Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
    May 22 We Think Cabaletta Bio (NASDAQ:CABA) Can Afford To Drive Business Growth
    May 15 Cabaletta Bio GAAP EPS of -$0.51
    May 15 Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
    May 13 Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
    May 5 Wall Street Breakfast: The Week Ahead
    Mar 23 Cabaletta Bio Inc (CABA) Earnings: Aligns with EPS Projections, Forecasts Extended Cash Runway
    See more CABA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.35
    52 Week Low 6.9
    Average Volume 1,469,614
    200-Day Moving Average 16.69
    50-Day Moving Average 10.92
    20-Day Moving Average 9.51
    10-Day Moving Average 8.00
    Average True Range 1.01
    RSI (14) 34.64
    ADX 24.21
    +DI 18.70
    -DI 30.88
    Chandelier Exit (Long, 3 ATRs) 10.47
    Chandelier Exit (Short, 3 ATRs) 9.93
    Upper Bollinger Bands 12.85
    Lower Bollinger Band 6.16
    Percent B (%b) 0.25
    BandWidth 70.40
    MACD Line -1.16
    MACD Signal Line -1.01
    MACD Histogram -0.1491
    Fundamentals Value
    Market Cap 334.65 Million
    Num Shares 42.8 Million
    EPS -1.70
    Price-to-Earnings (P/E) Ratio -4.59
    Price-to-Sales 0.00
    Price-to-Book 6.65
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.70
    Resistance 3 (R3) 8.62 8.25 8.55
    Resistance 2 (R2) 8.25 8.02 8.29 8.50
    Resistance 1 (R1) 8.03 7.89 8.14 8.11 8.45
    Pivot Point 7.66 7.66 7.72 7.70 7.66
    Support 1 (S1) 7.44 7.43 7.55 7.52 7.17
    Support 2 (S2) 7.07 7.30 7.11 7.12
    Support 3 (S3) 6.85 7.07 7.07
    Support 4 (S4) 6.93